ADARx Pharmaceuticals, Inc. (ADRX) News
Follow ADARx Pharmaceuticals, Inc. (ADRX) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
ADARx Pharmaceuticals Upsized IPO Priced at Top of Views
By Colin KellaherShares of ADARx Pharmaceuticals are due to make their trading debut Friday after the clinical-stage biotechnology company's upsized initial public offering was priced at the high end of expectations, rai
EQUITY | Sep 25, 2026, 12:04 PM UTC
L
ADARx Pharmaceuticals' 26.3M-Share IPO Prices at $17 a Share
ADARx Pharmaceuticals' 26.3M-Share IPO Prices at $17 a Share
EQUITY | Sep 24, 2026, 11:40 PM UTC